-
1 Comment
Guangdong VTR Bio-Tech Co., Ltd is currently in a long term downtrend where the price is trading 14.2% below its 200 day moving average.
From a valuation standpoint, the stock is 79.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.0.
Guangdong VTR Bio-Tech Co., Ltd's total revenue sank by 20.5% to $513M since the same quarter in the previous year.
Its net income has increased by 20.9% to $54M since the same quarter in the previous year.
Finally, its free cash flow grew by 69.7% to $91M since the same quarter in the previous year.
Based on the above factors, Guangdong VTR Bio-Tech Co., Ltd gets an overall score of 3/5.
Guangdong VTR Bio-Tech Co., Ltd., a biotechnology company, researches, develops, produces, and sells bio-enzyme preparations, biosynthetic products, and plant extracts in the biomanufacturing, agriculture, and animal husbandry industry in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, and pulp and paper products, as well as textile enzymes, including acid cellulase, neutral cellulase, catalase, alkaline protease, medium temperature desizing enzyme, etc. It provides Boluohui Extract, a veterinary drug raw material and powder; and other biotechnology solutions. The company also exports its products. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is based in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300381.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
